Related Experiment Video

Updated: Aug 6, 2026

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

Elevated endothelin-1 levels are associated with decreased arterial elasticity in hypertensive patients

Adviye Ergul1, Dena Jupin, Maribeth H Johnson

  • 1Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Athens, GA, USA. aergul@mcg.edu

Journal of Clinical Hypertension (Greenwich, Conn.)
|August 10, 2006
PubMed

Insights

Elevated endothelin-1 in hypertension is linked to reduced collagen breakdown and arterial stiffness. This suggests endothelin-1 may impair blood vessel function by inhibiting collagen degradation.

Area of Science:

  • Cardiovascular Physiology
  • Biochemistry
  • Hypertension Research

Background:

  • Endothelin-1 (ET-1) is known to stimulate collagen synthesis.
  • ET-1 levels are elevated in hypertension.
  • The impact of ET-1 on collagen degradation in hypertension is not well understood.

Purpose of the Study:

  • To investigate the association between elevated endothelin-1 levels and collagen degradation.
  • To examine the relationship between ET-1, collagen degradation markers, and arterial compliance in hypertensive patients.

Main Methods:

  • Recruited normotensive (n=10) and hypertensive (n=13) patients without antihypertensive medication.
  • Assessed arterial elasticity, systemic vascular resistance, pulse pressure, and blood pressure using waveform analysis.
  • Measured plasma endothelin-1 and collagen degradation products.

Main Results:

  • Hypertensive patients showed decreased large artery elasticity index and collagen degradation products.
  • Hypertensive patients exhibited elevated endothelin-1, systemic vascular resistance, and pulse pressure.
  • Plasma endothelin-1 negatively correlated with collagen degradation markers (cross-linked C-terminal telopeptide of collagen type I, matrix metalloproteinase-1) and large artery elasticity.
  • Plasma endothelin-1 positively correlated with pulse pressure.

Conclusions:

  • Endothelin-1 may contribute to decreased arterial compliance in hypertension.
  • ET-1 appears to inhibit collagen degradation, impacting arterial function.
  • Findings suggest a mechanism linking ET-1 to vascular dysfunction in hypertension.

More Related Videos

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Arteries and Arterioles01:16

Arteries and Arterioles

Arteries, the vasculature responsible for transporting blood from the heart, possess robust walls capable of enduring the elevated pressures exerted by the heartbeat. Arteries near the heart are especially thick-walled and enriched with elastic fibers across their three tunics, classifying them as elastic or conducting arteries. These arteries, usually with a diameter exceeding 10 mm, are characterized by their ability to dilate in response to the blood pumped from the heart's ventricles and...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...